|
| |
- BioPortfolio: Bio Vacancy - life science, pharmaceutical and biotechnology careers and jobs
- Bioportfolio - Bio-Vacancy BioJobNetwork
- LeadDiscovery/index.htm
- BioPortfolio InDepth Cancer Resource - abstract, publications, clinical trials, patents, news, companies
- BioPortfolio InDepth Infection Resource - abstract, publications, clinical trials, patents, news, companies
- Bioscience Trend Analysis
- BioPortfolio - Biotechnology, Pharmaceutical and Life Science Promotional Services
- BioPortfolio - Site Statistics
- Biotechnology, Pharmaceutical and Life Science postal mailing addresses for rental
- Biotechnology, Pharmaceutical and Life Science licensing, partnering program
- BioMarketing
- BioPortfolio Limited Site Map
- BioPortfolio
- BioPortfolio Limited Information
- cgi-bin/ca000001.pl
- cgi-bin/os000001.pl
- cgi-bin/mf000001.pl
- Synthetic Biology: A New Paradigm for Biological Discovery
- Influencing Brand Preferences in the Flow Cytometry Market
- The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume II
- Maximizing Market Share Through Brand Differentiation
- The Market for DNA Molecular Weight Markers: Climbing the Ladder to the Top
- Securing a Competitive Advantage in the Reverse Transcriptase Market
- The Market for Restriction Enzymes Cutting Out Your Competition
- Advertising to Life Scientists Maximizing Ad Effectiveness
- Marketing to Life Scientists Navigating Channels Through Segmentation
- The Taq Wars Competitive Intelligence on How to Survive
- Men's Health: The Market for Current and Emerging Drug Therapies, 2nd Edition
- Outsourcing in Drug Development: The Contract Research Market, 2nd Edition
- HIV: A Strategic Analysis of Therapeutic and Testing Markets
- Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Glucose Testing
- Medical Imaging Markets, Volume I: Radiography
- The Protein Therapeutics Market: The Science and Business of a Growing Sector<P>
- Medical and Biological Sensors and Sensor Systems: Markets, Applications, and Competitors Worldwide, 2nd Edition
- The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
- The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition
- The Global Market for Adjunctive Therapies in Cancer, 2nd Edition<P> <P>
- The World Market for Generic Drugs, 5th Edition
- The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products<P>
- Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery
- The U.S. Market for Private Label OTC Healthcare Products
- The Worldwide Market for Prescription Dermatological Drugs, 5th Edition
- Future of Biotechnology Instrumentation, The
- Long-Term Care Market, The
- Outsourcing in Drug Discovery, 2nd Edition
- Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing
- U.S. Market for Over-the-Counter Anti-Infectives, The
- Advanced Drug Delivery: Technologies, Applications, and Markets, 2nd Ed.
- Clinical Diagnostics in China: Market Sector Analyses and Participant Directory
- Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd edition, The
- World Market for Respiratory Equipment, The
- Worldwide Market for Pediatric Drugs, 2nd Edition, The
- U.S. Market for Clinical Information Systems: An Analysis of the Growing Use of Information Technology for Hospital-Based Patient Care, The
- Worldwide Market for Cancer Diagnostics, The
- Glycosylated Protein Therapeutics: A Market Briefing
- Implant-Based Dental Reconstruction: The Worldwide Implant and Bone Graft Market
- U.S. Market for Cardiovascular Devices, The
- World Market for Neurotherapeutic Drugs, The
- Wound Care Markets, 2nd Edition, Vol III: Surgical and Trauma Wounds
- Complex Regional Pain Syndrome (CRPS): A Market Briefing
- Market for Clinical Nutritional Products, The
- Wound Care Markets, 2nd Edition, Vol II: Burns
- U.S. Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications., The
- Wound Care Markets, 2nd Edition, Vol I: Skin Ulcers
- Minimally Invasive Spinal Surgery: A Market Briefing
- Molecular Imaging Agents and Systems: A Market Briefing
- Synthetic Blood Substitutes and Blood Products: A Market Briefing
- U.S. Market for Home Care Products, 4th Edition, The
- U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed.
- World Market for Anti-Infectives, Volume III: Antivirals, The
- The Outlook for RNA
- The Asthma, COPD & Allergic Rhinitis Market Outlook to 2011
- Pharmaceutical Licensing Strategies: Best practices in deal-making, valuations and strategic management
- The Pain Market Outlook to 2011
- Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics
- The Diabetes Market Outlook to 2011
- Pharmaceutical Growth Opportunities in the EU Accession States: Healthcare reform, market dynamics and key players
- Pharmaceutical Outsourcing Strategies - Market expansion, offshoring and strategic management in the CRO and CMO marketplace
- Opportunities in Stem Cell Research and Commercialization - Technology advances, regulatory impact and key players
- Winning Pharmaceutical Brand Management - Maximizing brand value through best practice in brand development and product marketing
- Predictive ADME and Toxicology Strategies - Challenges and opportunities for in vivo, in vitro and in silico predictive technologies
- The Top 10 Generics Companies: Strategic insight, growth opportunities and competitive dynamics in the US and Europe
- Lifecycle Management Strategies: Maximizing ROI through indication expansion, reformulation and Rx-to-OTC switching
- The Outlook For RNAi: Accelerating drug discovery and the development of RNAi therapeutics
- The Future Of Array Technologies: Impact on drug discovery and market growth in DNA, protein and tissue arrays
- The Future of Systems Biology: Emerging technologies and their impact on drug discovery, development and diagnostics
- Lead Optimization Strategies: Future developments, threats and opportunities for big pharma, specialty pharma and biotech
- The Latin American Cardiovascular Market Outlook to 2010
- The Gastrointestinal Market Outlook to 2010
- Pharmaceutical Branding Strategies: Thought leader perspectives on brand building, effective communication and future brand models
- The Asian Cardiovascular Market Outlook to 2010
- The Eastern European Cardiovascular Market Outlook to 2010
- The Eastern European Cancer Market Outlook to 2010
- The Asian Cancer Market Outlook to 2010
- The Latin American Cancer Market Outlook to 2010
- The Emerging Drug Targets Outlook: An analysis of novel molecular targets to develop innovative new therapeutics
- The Cancer Market Outlook to 2010
- The Biotechnology Market Outlook: Growth opportunities and effective strategies for licensing and collaborations
- Health Care Equipment & Supplies: Global Industry Guide
- Ovarian Cancer - Growing importance as secondary indication for targeted therapies
- Commercial Insight Top 20 Cancer Therapeutics
- Systemic Lupus Erythematosus - On the Verge of a Breakthough
- Commercial Insight: Transplantation
- Pipeline Insight: Hepatitis C - Protease inhibitors to drive market expansion
- Pharmaceutical Outsourcing Part 1: Contract Manufacturing Strategies - Offshoring is not the only option to drive productivity and efficiencies
- Global Generics Guide: Part 2 - Benchmarking country markets and strategic issues
- Pricing and Reimbursement in the US: Innovation and robust pharmacoeconomic analysis are key
- Mid Pharma Sector: In-licensing and other externalization strategies
- Management of Urinary Incontinence and Overactive Bladder - A Global Overview
- Cancer Biomarkers: Enhancing diagnostic, therapeutic and developmental strategies
- Antiarrhythmics - RSD1235 in a class of its own
- Directed Molecular Evolution: Product lifecycle management for biologics
- Global Generics Guide: Benchmarking the key players
- Parallel Trade in Europe and the US: The challenges facing pharma
- Dry Overactive Bladder - A Precursor to 'Wet Overactive Bladder'?
- Urge Urinary Incontinence - Poor Differentiation Limiting New Product Uptake
- Stress Urinary Incontinence - Opinion Divided on Drug Therapy
- Mixed Urinary Incontinence - An Opportunity for Novel Drug Therapies
- Interstitial Cystitis - Few Treatments, Poor Outcome
- Immunotherapy in Allergic Rhinitis - Moving away from injections
- Personalizing Disease Management Through Technology Solutions - Part II - Vendor Landscape
- Metabolic Syndrome - Multiple definitions complicate treatment
- Major Depressive Disorder - Duloxetine - Fulfilling An Unmet Need?
- Kidney Transplantation - Switching to calcineurin inhibitor-free immunosuppression
- Non-Small Cell Lung Cancer Avastin to lead the market
- Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
- Acute Leukemias - Persistent unmet needs confer significant commercial opportunity
- Osteoarthritis - Preconceptions Damage Awareness and Treatments
- Anxiety Disorders - A decade of declining revenues
- Antihypertensives - Weak pipeline leaves innovation to Novartis
- Acute Stroke - Considerable unmet need is balanced by substantial commercial risk
- The Pharmaceutical Industry - Key events and trends shaping its current status and future direction
- Urinary Incontinence and Overactive Bladder - The Perspective of the Continence Nurse in the US
- Stakeholder Opinions - Sepsis - Under reaction to an overreaction
- Personalizing Disease Management through Technology Solutions - Part I
- The eHealth Market in Italy and Spain: Key Trends in Physician Channels of Influence
- Monoclonal Antibodies in Asthma: The choice between life and breath?
- Stakeholder Opinions: Cystic Fibrosis
- Maximizing eHealth Tools for Caregivers: Cultivating Long-Term Relationships
- Pulmonary Arterial Hypertension - A small market gets big attention
- The Changing Patient-Physician Relationship Part 2: the Physician's Perspective
- Optimizing Sales Force Effectiveness: Using eHealth Applications to Improve the Quality of Physician Interactions
- Pharmaceuticals: Global Industry Guide
- Commercial Perspectives: Drug Treatment in End-Stage Renal Disease - The Price of Failure
- Stakeholder Perspectives: Influenza Vaccines - Flying back Into Flu
- Commercial Insight: Antidyslipidemics - Statins Hit the Brakes on Market Growth
- Stakeholder Opinions: Renal Cell Carcinoma - Novel Targeted Treatments to Fill the Void
- Commercial Insight: Antihypertensives - Two Years to Shape the Market?
- Stakeholder Insight: Orthopedic Postoperative Pain - Old Habits Hurt Market Potential
- Stakeholder Insight: Hepatitis in China - Liver Let Die?
- Commercial Insight: Disease Modification in Rheumatoid Arthritis - The Biologics Boom
- Pipeline and Commercial Perspectives: Insomnia
- Commercial Insight: Generic Cancer Market - New Legislation and a Wave of Patent Expiries to Transform the Market
- Marketing Drugs in an Era of Pharmacovigilance - Best practice after drug safety scares and the implications for the future
- Opioid Abuse - Hooked on Generics?
- Stakeholder Insight: COPD - Another Reason to Quit
- Juvenile Arthritis - A Niche In The Market
- Therapeutic Vaccines: More Trials and Tribulations
- Inhalable Drug Delivery: Industry Holds its Breath in Anticipation of Systemic Success
- Stakeholder Insight: Hypertension - Multiple Layers of Therapy Cover all Eventualities
- Reaching Endocrinologists Online: Strategies for Building Brand Equity
- Pharmacovigilance: A New Era of Drug Safety
- India's Growth Prospects in Pharma: Evolution, Not Revolution
- Medicare Part D - Its impact on US drug pricing issues and role as a driver towards European style pricing mechanisms
- Pipeline Insight: Chronic and Acute Heart Failure - Diversity and Disappointment
- Drug Delivery: Global Industry Guide
- eHealth During the Clinical Trial Process - Trends in Study Participation and Clinical Trial Website Usage
- The eHealth Market in Japan: Optimizing eHealth Tools for Reaching Consumers
- Stakeholder Opinions: Sexually Transmitted Infections - The Silent Menace
- Commercial Insight: Asthma and COPD - Get SMART
- Datamonitor's eHealth Consumer Insight Survey: 2005 Survey Results Overview
- PROactive Results - The Diabetes Trial That Could Have Been
- Biogenerics 2005: A New Level of Complexity
- The eHealth Market in Japan: Building Physician Loyalty Via Online Tools
- Osteoporosis - The Science of Compliance
- Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
- Herpes and Respiratory Antivirals - Leaders Rise and Fall
- Myelodysplastic Syndrome - An underserved population offers commercial opportunity
- Stakeholder Insight: HIV - A way of life
- Licensing Strategies: Trends in the top 20 pharmaceutical companies' activity
- Prostate Cancer - A Prostrate Market Waiting for Innovations
- BioPortfolio Limited La Merie
- R&D Pipeline News is a premier information source about research and development (R&D) projects
- cgi-bin/acatalog/R&D_Pipeline_News_Therapeutic_Area_issue_free_sample.PDF
- The Global Drug Delivery Market: Research Trends and Market Outlook
- Pharmaceutical and Biotech Market Entrance Strategies Pricing, Reimbursement and Parallel Trade
- Cancer Therapeutics 2006 - Market Dynamics and R&D - the four major cancer markets, which include colorectal, prostate, lung and breast cancer were valued at well over $16 billion in 2005,
- US and European Prescription Generic Markets - An Examination of Commercial and Regulatory Contrasts.
- Amgen - Profile, Patents and Pipeline - Can Amgen continue its amazing revenue growth? Or will it fall behind, lacking the small molecule therapeutics
- Pain Therapeutics 2005: Market Dynamics and Outlook - provides detailed analysis and information concerning the global market for pain therapeutics, R&D pipelines and company involvement in this field
- STRATEGIES FOR INNOVATION IN PHARMACEUTICAL R&D - written to provide members of pharmaceutical, biotechnology and clinical research sectors an analytically-based overview of the mechanisms of the partnering process
- Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition
- Business Opportunities in China: The impact of the WTO
- Legal aspects of outsourcing contracts in the pharmaceutical industry: A practical guide
- cgi-bin/acatalog/Legal aspects of outsourcing media pack.pdf
- The Licensing Agreement in Pharmaceutical Business Development (2nd Edition)
- Partneringdesk Deals and Alliances therapy report
- BioPortfolio Limited Partneringdesk Deals Briefings
- Partneringweek
- Partneringreview 2006
- cgi-bin/acatalog/PartneringReview_Detailed_Sample.pdf
- Biopharmaceutical Manufacturing Capacity and Production - comprehensive look at the state of worldwide biopharmaceutical manufacturing
- BIOPHARMA: Biopharmaceutical Products in the U.S. Market The only biopharmaceutical products reference! 3rd edition - see 4th addition above
- Biopharmaceuticals in the US and European Markets, 4th Edition The only biopharmaceutical reference! Invaluable for general, technical, and competitive information
- Neuro Stents & Coils Technology Market Forecast - The landscape of management options for cerebral aneurysms is changing fast.
- Carotid Stents Technology and Market Forecast - Carotid Angioplasty and Stenting (CAS) has recently emerged as a popular alternative to endarterectomy
- Drug Eluting Stents Technology and Market Forecast - Latest research findings indicate that drug eluting stents (DES) reduce the need for re-intervention after PTCA to a greater extent than bare metal stents (BMS).
- Pharmacogenomic Testing Markets
- Point of Care Diagnostic Testing Sector Trends
- Microarray Markets
- Cytology and HPV Testing World Markets
- Indian Pharmaceutical Industry
- Medical Imaging Markets
- Bioinformatics State of the Art - report is arranged to provide an overview of bioinformatics market segments and offer evidence that these segments are poised for high future growth
- Disposable Syringes Markets - report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications
- High-Growth Diagnostics Tests Markets - report is to describe the specific market segment of the in vitro diagnostics market called high-growth diagnostic testing
- Cardiac Marker Diagnostic Tests Markets - report is to present an overview of the diagnostic testing cardiac marker market with the latest information regarding emerging new products and industry trends
- Genomics World Markets - report develops forecasts for genomics-based products, services, and applications from 2000 through 2005
- Cancer Diagnostic Testing World Market report deals with the analysis of analytes that are related to the common chemical constituents of blood, plasma or serum that are related to the growth and progress of cancer.
- Clinical Chemistry Analyzers - companies and products that are actively developing and marketing chemistry analyzer products for the clinical setting, including hospitals, independent labs, physician's offices, and miscellaneous clinics.
- Molecular Diagnostics Markets - a comprehensive look at various platform technologies for molecular diagnostics, including immunoassays, probe-based nucleic acid assays, microarrays, and sequencing
- Point Of Care Diagnostic Testing World Markets - eport deals with the analysis of analytes that are related to the common chemical constituents of blood, plasma or serum at the point of care of the patient
- Veterinary Health Markets - report concentrates on the supplies, supplements and consumables used in this area the veterinary health market segment
- Diabetes, Metabolic Syndrome & Cardiovascular Disease - report is to describe the specific market segment of the pharmaceutical market of diabetes, metabolic syndrome, and cardiovascular disease
- Over The Counter Diagnostic Product World Markets - deals with the analysis of chemical constituents of blood, plasma or serum, or urine that are related to the growth and progress of disease
- Cancer Therapeutics Markets The report develops forecasts for anti-cancer based products from 2001 through 2005.
- Medical Device Product Management: Benchmarking Development, Marketing and Promotion (PH80)
- Pharmaceutical Market Segmentation: Spending, Strategy and Implementation (PH82)
- Blockbuster Pharmaceutical Launches: Establishing Market Leadership (PH85)
- Marketing Mid-Tier Pharmaceutical Brands: Winning Resources for Near-Blockbusters (PH84)
- Small And Specialty Drug Branding: Tapping Niche Market Potential (PH83)
- Medical Affairs: Evolving with the Compliance Environment (PH74)
- Combating Generics: Pharmaceutical Brand Defense for 2007 (PH76)
- Managed Markets 2007: Pharmaceutical Reimbursement Strategy, Organizational Structure and Medicare Part D (PH77)
- Pharmaceutical Co-Promotion Management (PH78)
- Managing Investigator Initiated Clinical Trials: Structure, Process and Strategy (PH81)
- Pharmaceutical Pricing in the US and Europe: Analysis of Resources, Strategy and Structure (PH73)
- European Pharmaceutical Marketing: Launching Successful Brands (PH71) - a unique blend of competitive pressures, clinical proficiency, commercial prospects, and regulatory hurdles
- Business Development Spending and Structure: Priming the Pharmaceutical Pipeline (PH70) - report features qualitative and quantitative findings from 22 different companies that range from the industry's top ten to up-and-coming biotechs.
- Pharmaceutical Sales: Driving Access and Influencing Prescribers (PH65) - Over the next decade, the pharmaceutical sales landscape faces dramatic changes.
- Defending Brand Revenue: Pharmaceutical Lifecycle Management Planning (PH69) - strategies to maximize branded drugs’ profitability is a key strategy for the pharmaceutical industry
- Oncology Brand Commercialization: Resource Allocation (PH68) - This report looks across the industry to identify key factors in oncology brand commercialization.
- In Silico ADME/Tox Products Market 2006
- cgi-bin/acatalog/TOC_Adme_Tox.pdf
- Stem Cells 2006
- RNAi - technologies, markets and companies - Profiles of 119 companies involved in developing RNAi technologies are presented along with 84 collaborations
- cgi-bin/acatalog/rnaijain.pdf
- Molecular Diagnostics 2005 - report analyzes the technologies and their impact in the molecular diagnostics marketplace
- cgi-bin/acatalog/moldiaTOC.pdf
- Biomarkers - technologies,markets and companies
- Cardiovascular Drug Delivery - technologies, markets and companies - Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to al
- Molecular Diagnostics - Technologies, Markets and Companies - This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biolog
- Cell Therapy - Technologies, Markets and Companies - This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine.
- Proteomics - Technologies, Markets and Companies - This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era
- Neuroprotection - Drugs, Markets and Companies - This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders
- Transdermal Drug Delivery - Technologies, Markets, and Companies - This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmuc
- Animal Biotechnology - Technologies, Markets and Companies - This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production.
- Pain Therapeutics - Drugs, Markets and Companies - This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain.
- Nitric Oxide - Therapeutics, Markets and Companies - This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.
- Alzheimer disease - new drugs, markets and companies - Alzheimer's disease remains a challenge in management.
- Drug Delivery in Cancer - technologies, markets and companies - Innovative cancer therapies are based on current concepts of molecular biology of cancer.
- RNAi - technologies, markets and companies - RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA).
- Gene Therapy - technologies, markets and companies - Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state.
- Nanobiotechnologies- applications, markets and companies - Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one billionth of a meter.
- Drug Delivery in Central Nervous System Disorders - The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders.
- Biogenerics 2006: Challenges ahead for an emerging market
- Indian Pharmaceutical Market, 2006-2011
- Product Lifecycle Management, 2006
- The World Generics Market 2006-2011
- The World Diabetes Market, 2005-2011
- The Clinical Trials Market 2006
- The World Gastrointestinal Disorders Market 2006-2011
- Japanese Pharmaceutical Market, 2006-2011
- The World Market for Antidepressants, 2006
- The World’s Top Ten Generic Companies
- The World Hypertension Market 2005-2010
- Pfizer - Current Difficulties and Future Challenges, 2005-2010 - Pfizer has just issued a warning on how deep the pharmaceutical industry's problems have gone.
- The World Sleep Disorders Market, 2005-2010 - The sleep disorder treatment market had sales of $2.03bn in 2004. It is dominated by one product, Ambien indicated for the short-term treatment of insomnia
- The World Schizophrenia Market 2005-2010 - The schizophrenia world market generated total revenues of nearly $12 billion in 2004.
- Pricing and Reimbursement 2005 - 2006, Evaluating Key Strategic Issues - persuading the country in question to reimburse them, that is pay for the drug that the company is attempting to market.
- The World Biotech Market 2005 - The biopharmaceutical market has undergone rapid expansion since its emergence thirty years ago. No longer is the market confined to growth hormones, insulin and red blood cell stimulating agents.
- The World Pharmaceutical Wholesale and Distribution Industry 2005 - The Pharmaceutical Wholesale and Distribution Industry has survived on continual low profits while the pharmaceutical companies of whom its serves continues to thrive.
- World Neurodegeneratives Disease Markets, 2005-2009 - Is the neurodegeneratives disease market growing? Are current drug therapies valuable?
- Urinary Track Agents Annual Report 2005 - Urinary tract agents (UTAs) are simply drugs used to treat disorders of the urinary tract.
- The Global Endocrine Pharmaceutical Market 2005 pharmaceutical market is a highly lucrative multi-billion dollar business, but, can you confidently answer the following
- The Global Veterinary Pharmaceutical Market - The animal health businesses of the major pharma companies have two parts: one for food producing animals and one for companion animals such as dogs and cats.
- Anticonvulsants 2005 - Anticonvulsant therapies encompass all drugs used primarily to prevent seizures or control their incidence or severity.
- Therapeutic Proteins - Proteins that are engineered in the laboratory for pharmaceutical use are known as therapeutic proteins.
- Cannabinoids: A potential blockbuster - cannabinoid market is undergoing rapid expansion. Currently just two products are available on this controversial market: Marinol from Unimed Pharmaceuticals and Nabilone marketed by Cambridge Laboratories.
- Pharmacoeconomics is the branch of economics that applies cost-benefit, cost-effectiveness, cost-minimisation, and cost-utility analyses
- BioPortfolio Limited BioPortfolio Membership
- pdf/BioNewsCast.pdf
- Colony Stimulating Factors Current Market Dynamics & Future Outlook - By the end of 2004 the world market for Colony Stimulating Factors was valued at $3.6 billion, a growth of 11% over 2003.
- Erythropoietin State of the Science and Strategic Opportunities - The market for Erythropoietin is very lucrative. Marketing costs are low due to the well-defined patient population and distribution costs are low due to the limited distribution outlets.
- Monoclonal Antibody Therapeutics - Current Market Dynamics & Future Outlook - The global market for Monoclonal Antibody (Mab) Therapeutics reached a total of $11.2 billion in 2004
- Biopharmaceuticals Current Market Dynamics & Future Outlook - Over 130 such products are currently being marketed around the world including thirteen blockbuster drugs.
- Interferon State of the Science and Strategic Opportunities - The interferon market is application driven and clearly demarcated along the lines of the type of the interferon molecule.
- Pharmaceutical Market Trends, 2006-2010 Key market forecasts and growth opportunities
- Major Pharmaceutical Markets of the Middle East An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE
- cgi-bin/acatalog/pharma_markets_Middle_East_Exec_Summary.pdf
- Preparing Health Technology Submissions for Pharmaceutical Products
- cgi-bin/acatalog/urch_exec_sum_health_tech_subs.pdf
- Global BioGenerics Market in 2010
- Guide to Pharma Pricing & Reimbursement Systems western Europe
- Pricing & Reimbursement of Medicines in the United Kingdom - Understanding the pharmaceutical market in the healthcare system<P><P>National pharmaceutical pricing and reimbursement is a complex and ever-changing area.
- Atrial Fibrillation: Emerging drug discovery targets and therapeutic candidates
- BAFF (BLys) & APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- Autoimmune Disorders & Transplant Rejection - Opportunities for the Drug Development Sector
- Histone deacetylase inhibitors: Moving from the bench to a promising companion for classic and targeted cancer therapies - The exponential growth in the level of research activity surrounding the histone deacetylases (HDACs) witnessed over the past decade
- 5-HT7 antagonists: Novel molecules for the unmet migraine prophylaxis market
- The retinoids : Therapeutic & pharmaceutical opportunities - Members of the retinoid family have long been known to be physiological regulators of a range of essential biological processes, including vision, embryonic development, reproduction, and bone f
- Rheumatoid arthritis: Emerging drug discovery targets and therapeutic candidates
- Asthma Therapeutics: New treatment options and emerging drug discovery targets
- American Hospital Register
- cgi-bin/acatalog/AHRscreens1.doc
- European Hospital Register This easy-to-use CD ROM contains information on over 16,000 hospitals in 20 countries.
- cgi-bin/acatalog/EHRBrochure.pdf
- Sleeper Diseases: Forecast and Assessment of Neglected Disease Market Opportunities
- Oncogenomics: The Future of Cancer Care
- A New Paradigm for Clinical Development: The Clinical Trial in 2015
- Pain Therapeutics: New Times, New Targets
- cgi-bin/acatalog/9216_pain.pdf
- Transmembrane Transporters High Sales, High Potential as Drug Targets
- cgi-bin/acatalog/9212_Transporters_sample_content.pdf
- Guide to Business and Regulatory Strategies
- cgi-bin/acatalog/9209_DxRx_Business_and_Regulatory_Strategy.pdf
- Growth and Technological Advances of the Biodisposables Market
- cgi-bin/acatalog/9215_Disposables.pdf
- COPD Drug Discovery How New Generation Therapies Seek to Target Underlying Disease
- cgi-bin/acatalog/9218_COPD_sample_content.pdf
- Peptides 2006 New Applications in Discovery, Manufacturing, and Therapeutics
- cgi-bin/acatalog/9214_peptides.pdf
- Guide to US Reimbursement for Drugs, Medical Devices, and Diagnostics
- cgi-bin/acatalog/9202_Reimbursement_Drugs_Medical_Devices_Diagnostics.pdf
- Life Science Mergers & Acquisitions
- cgi-bin/acatalog/9197_life_sciences_mergers_acquisitions.pdf
- High-Content Screening (HCS): An Industry Analysis
- Developing and Managing Successful Bio-Outsourcing Relationships
- Breast Cancer Therapeutics
- Cell Therapy Commercialization<P>Applying Stem Cell and Related Strategies
- How to Succeed in Personalized Medicine by Using Tools and Technologies
- Protein Therapeutics Production
- Bioprocesses of Biopharmaceuticals: The Obligatory Role of Post Translational Modifications to Create Functional Bioactive Molecules
- Market Opportunities and Challenges for Antibody Arrays and Beads: A Market Research Study
- Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics 2nd edition
- BioPortfolio Limited G-Protein Coupled Receptors (GPCRs) Technical Over
- BioPortfolio Limited Prions: A Primer for the Biopharmaceutical Industr
- BioPortfolio Limited Solving Drug Discovery with Metabolomics and Metab
- BioPortfolio Limited RNAi: Broad Application, Expansive Opportunity, 2n
- cgi-bin/acatalog/9164_RNAI.pdf
- BioPortfolio Limited Ethical Issues in Drug Development - A Deterrent T
- cgi-bin/acatalog/Ethical_Issues.pdf
- BioPortfolio Limited Proteases as Drug Targets - Technologies and Oppor
- cgi-bin/acatalog/Proteases_toc_es.pdf
- BioPortfolio Limited Protein-Protein Interactions as Drug Targets: Focu
- cgi-bin/acatalog/protein_interaction_content.pdf
- Life Sciences Mergers & Acquisitions (M&A)
- LifescienceIC Analysis of the applications and added value of semiconductor devices in life sciences
- China Pharmaceutical Guidebook Series (4)
- China Pharmaceutical Guidebook Series (3) Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration
- A Guidebook of Registration Application for Imported Chemical Drugs
- China Pharmaceutical Guidebook Series (1)
- How to Merge the Chinese Enterprises
- Chinese Pharmaceutical Industry
- BioPortfolio Limited Specials
- BioPortfolio Site Search Tools
- Contact and Help files on BioPortfolio
- Submit your Press Release URL
- Submit your URL
- Add BioNews to your website using RSS JavaScript, a search box or URL link
- Embed RSS feed on webpage - Prostate Cancer sample
- Embed RSS feed on webpage - HIV AIDS sample
- Channels on BioPortfolio
- BioWatch Biotechnology and Pharmaceutical News Tracking
- BioWatch News Sample
- BioPortfolio's BioWatch News Gold Membership form
- BioWatch News Platinum Subscription
- BioWatch News Platinum Subscription
- BioWatch News Gold Subscription
- BioWatch News Gold Subscription
- BioPortfolio BioWatch News Tracking and Awareness service FAQs
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental - pricing
- BioWatch Biotechnology and Pharmaceutical News Tracking RSS
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental - datasheets
- pdf/European Scientists working on HPLC and Chromatography.pdf
- pdf/stemcellfrance-listinfo.pdf
- pdf/infectious_diseases.pdf
- pdf/senior_corporate_europe.pdf
- pdf/commercial_life_scientists_UK..pdf
- pdf/UK_Commercial_Life_Scientists.pdf
- pdf/Pathology_Prions_Viruses_Bacteria_EUROPE.pdf
- pdf/stemcell-immuno-listinfo.pdf
- pdf/proteomics-listinfo.pdf
- pdf/commercial_life_science.pdf
- pdf/fermentors.pdf
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental - Agreement
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental - Company
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental - Gene
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental - Diseases
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental - Subject
- Biotechnology, Pharmaceutical and Life Science Email addresses for rental - Techniques
- Email Legislation
- Pharmaceutical, Drug Development and Discovery email list
- pdf/pharma-listinfo.pdf
- BioEmail targeted email Immunology List
- pdf/immunology-listinfo.pdf
- Neurodegenerative diseases email list
- pdf/neurodegeneration-listinfo.pdf
- BioEmail targeted email ELISA – Enzyme Linked Immunosorbent Assay email list
- pdf/elisa-listinfo.pdf
- Stem Cell Scientists Email List
- pdf/stemcell-listinfo.pdf
- pdf/leukemia-listinfo.pdf
- pdf/microarray-listinfo.pdf
- pdf/hiv-listinfo.pdf
- pdf/usa-pcr.pdf
- pdf/humanoncology.pdf
- pdf/adademic-immune.pdf
- pdf/medchem.pdf
- pdf/gcmstox.pdf
- pdf/massspec.pdf
- Biotechnology, Pharmaceutical and Life Science licensing, partnering program
- conference/main.php
- BioNewsCast - press release publications and distribution service for the life science industry
- cgi-bin/acatalog/Biotech_Learning_Institute_eLearning_online_courses.html
- BioJournal - research, technical and investor information
- Kalorama Market Research
- cgi-bin/acatalog/Growing_Out_of_Pocket_Healthcare_Market_-_Spending_on_Surgeries__Pharmaceuticals_and_Other_Healthcare_Services.html
- cgi-bin/acatalog/Pediatric_Drugs__the_Worldwide_Market__3rd_Edition.html
- cgi-bin/acatalog/Offshoring_Clinical_Trials__The_Market_for_Clinical_Trials_in_India__China__Mexico__Brazil__Russia_and_Israel._.html
- cgi-bin/acatalog/OEM_Contract_Manufacturing_in_Medical_Devices__World_Market__Vol_III__Finished_Clinical_Products_and_Systems.html
- cgi-bin/acatalog/Cell-Based_Diagnostics__Technology__Applications__and_Markets__2nd_Edition.html
- cgi-bin/acatalog/Analytical_Chip_Technology__U.S._Markets_for_Lab_on_a_Chip__DNA_Gene__Protein__and_other_Microarrays__3rd._Edition.html
- cgi-bin/acatalog/World_Market_for_Prescription_Cardiovascular_Drugs__2nd_Edition__The.html
- cgi-bin/acatalog/Healthcare_Opportunities_for_Food_Ingredient_Manufacturers.html
- cgi-bin/acatalog/OEM_Contract_Manufacturing_in_Medical_Devices_Vol_II_-_Electronics_and_Advanced_Systems.html
- cgi-bin/acatalog/Retail_Clinics_-_The_Emerging_Market_for_Convenience_and_In-Store_Healthcare.html
- cgi-bin/acatalog/Prescribing_Pharmacists_-_A_Decision_Maker_Emerges.html
- cgi-bin/acatalog/A_Guide_to_Drug_Pricing_and_Reimbursement.html
- cgi-bin/acatalog/Orthopedic_Biomaterials_The_World_Market_2nd_Edition.html
- cgi-bin/acatalog/Wound_Care_3rd_Edition_Vol_III_Surgical_and_Trauma_Wounds.html
- cgi-bin/acatalog/Wound_Care_3rd_Edition_Vol_II_Burns.html
- cgi-bin/acatalog/OEM_Contract_Manufacturing_in_Medical_Devices_Vol_I_Materials_Processing.html
- cgi-bin/acatalog/Clinical_Nutrition_Products_World_Market_2nd_Edition.html
- cgi-bin/acatalog/Global_Hepatitis_Strategies.html
- cgi-bin/acatalog/Virtual_Reality_Applications_in_Healthcare_U.S._Market.html
- cgi-bin/acatalog/Anesthesia_Drugs_Worldwide_Markets.html
- cgi-bin/acatalog/Wound_Care_Markets_3rd._Edition_Vol._I_Skin_Ulcers.html
- cgi-bin/acatalog/The_Diagnostic_Equipment_Service_Conundrum_How_Much_Is_Too_Much__How_Little_Is_Too_Little_.html
- cgi-bin/acatalog/DNA_Sequencing_Equipment_and_Services_Markets.html
- cgi-bin/acatalog/Multiple_Sclerosis_World_Market_Outlook_to_2011.html
- cgi-bin/acatalog/Early_Toxicology_Markets_and_Approaches.html
- cgi-bin/acatalog/Global_Tuberculosis_Strategies.html
- cgi-bin/acatalog/BioPortfolio_RFID_Opportunities_in_Healthcare_in_the_U_S__755.html
- cgi-bin/acatalog/Asian_Medical_Device_Markets.html
- cgi-bin/acatalog/U.S._Market_for_Home_Care_Products_5th_Edition.html
- cgi-bin/acatalog/Physician_Office_Laboratory__POL__Testing_Markets_Worldwide_Status_Quo_and_Future_Trends.html
- cgi-bin/acatalog/Medical_Imaging_Markets_Volume_V_Molecular_Imaging.html
- cgi-bin/acatalog/Anti-Infectives_World_Markets_2nd_Edition_Vol._I-III_Complete_Series.html
- cgi-bin/acatalog/Anti-Infectives_World_Market_2nd_Edition_Vol_III_Antivirals.html
- cgi-bin/acatalog/Monoclonal_Antibodies_Vaccines_and_Other_Immunologic_Cancer_Treatments_World_Market.html
- cgi-bin/acatalog/Drug_Delivery_Markets_Vol_IV_Transdermal.html
- cgi-bin/acatalog/Anti-Infectives_World_Market_2nd_Edition_Vol_I_Antifungals.html
- cgi-bin/acatalog/Drug_Delivery_Series_I-IV.html
- cgi-bin/acatalog/Refractive_Vision_Correction_A_Market_Analysis.html
- cgi-bin/acatalog/Smoking_Cessation_and_Addiction_Treatments_A_World_Market_Analysis.html
- cgi-bin/acatalog/Diabetes_and_Diabetic_Complications_Major_World_Markets_3rd_Edition.html
- cgi-bin/acatalog/Medical_Imaging_Markets_Volume_IV_Contrast_Agents.html
- cgi-bin/acatalog/Drug_Delivery_Markets_Vol_III_Pulmonary_Delivery_Systems.html
- cgi-bin/acatalog/Molecular_Diagnostics_Major_World_Markets.html
- cgi-bin/acatalog/Cancer_Therapeutics_The_Worldwide_Market_2nd_Edition.html
- cgi-bin/acatalog/Drug_Delivery_Markets_Vol_II_Implantable_Injectable.html
- cgi-bin/acatalog/US._Market_for_EMR_Technologies_Electronic_Medical_Records.html
- cgi-bin/acatalog/Wireless_Opportunities_in_Healthcare.html
- cgi-bin/acatalog/Lateral_Flow_Technology_and_the_Future_of_Point_of_Care_Diagnostics.html
- cgi-bin/acatalog/Molecular_Diagnostics_-_Major_World_Markets.html
- cgi-bin/acatalog/Clinical_Diagnostics_in_India_-_Market_Sector_Analyses_and_Participant_Directory.html
- cgi-bin/acatalog/The_Worldwide_Market_for_Dialysis_Equipment_Supplies_and_Services_2nd_Edition.html
- cgi-bin/acatalog/Vaccines_-_The_World_Market.html
- cgi-bin/acatalog/The_World_Market_for_Psychotherapeutic_Drugs.html
- cgi-bin/acatalog/Drug_Delivery_Markets_Vol_I_-_Oral_Delivery.html
- cgi-bin/acatalog/The_World_Market_for_Pain_Management_Drugs_and_Devices__2nd_Edition.html
- cgi-bin/acatalog/Cell_Culture_-_The_World_Market_for_Media__Sera__and_Reagents.html
- cgi-bin/acatalog/Biomarkers_-_A_Market_Briefing.html
- cgi-bin/acatalog/Biophotonics_-_A_Strategic_Assessment_of_Photonics_Technologies_for_Biomedical_Applications.html
- cgi-bin/acatalog/Worldwide_Point_of_Care__POC__-_Are_Decentralized_Clinical_Diagnostics_a_Cost_Drain_or_Revenue_Driver_.html
- cgi-bin/acatalog/Mass_Spectrometry_in_Protein_Biomarker_Applications_-_Software__Services__and_Instrument_Markets.html
- cgi-bin/acatalog/The_Emerging_Cancer_Vaccine_Market__2nd_Edition.html
- cgi-bin/acatalog/Obesity_-_The_Worldwide_Market_for_Pharmaceutical_and_Surgical_Treatment.html
- cgi-bin/acatalog/Cardiac_Markers.html
- cgi-bin/acatalog/Medical_Imaging_Markets__Volume_III_-_Ultrasound.html
- cgi-bin/acatalog/The_World_Market_for_Prescription_Orthopedic_Drugs.html
- cgi-bin/acatalog/The_World_Market_for_Prescription_Respiratory_Drugs.html
- cgi-bin/acatalog/Psoriasis_and_Psoriatic_Arthritis_-_A_Strategic_Analysis_of_the_Market_in_the_United_States.html
- cgi-bin/acatalog/Pharmaceutical_Outsourcing_Opportunities_Post-Launch_-_Contract_Manufacturing_and_Contract_Sales_and_Marketing__2nd_Edition.html
- cgi-bin/acatalog/Blood_-_The_Worldwide_Market_for_Blood_Products_Blood_Testing_Blood_Equipment_and_Synthetic_Blood_Products.html
- cgi-bin/acatalog/Medical_Imaging_Markets_Volume_II_Magnetic_Resonance.html
- cgi-bin/acatalog/Women_s_Health__Worldwide_Prescription_Drug_Markets.html
- cgi-bin/acatalog/The_World_Market_for_Prescription_Gastrointestinal_Drugs.html
- Pharmalicensing Report
- cgi-bin/acatalog/Early_Stage_and_Discovery_Deals_Strategy_Structure_and_Payment_Terms_2nd_Edition.html
- LeadDiscovery
- Drug and Market Development
- cgi-bin/acatalog/Expanding_Opportunities_in_Contract_Research_and_Contract_Manufacture_of_Biotherapeutics_Biologics.html
- cgi-bin/acatalog/Prescription_Drug_Counterfeiting.html
- cgi-bin/acatalog/copy_of_Preparing_the_Common_Technical_Document_CTD_for_CMC.html
- cgi-bin/acatalog/Transdermal_and_Transmucosal_Delivery_of_Therapeutics_2nd_Edition.html
- cgi-bin/acatalog/Market_Opportunity_in_the_G-Protein_Coupled_Receptors_GPCRs_Target_Space.html
- cgi-bin/acatalog/Current_Drug_Development_Market_for_Cytokines_Chemokines_and_Growth_Factors.html
- cgi-bin/acatalog/Discovery_to_IND_Filing_2nd_Edition.html
- cgi-bin/acatalog/Molecular_Diagnostics_-_Effective_Tools_for_Disease_Management__3rd_Edition.html
- cgi-bin/acatalog/Commercial_Opportunities_for_Enzyme_Technologies__3rd_Edition_.html
- cgi-bin/acatalog/Impact_of_Nano_Materials_in_Drug_Delivery_and_Human_Tissue_Engineering.html
- cgi-bin/acatalog/Antibody_Therapeutics_-_Product_Development__Market_Trends__and_Strategic_Issues__Revised_Edition.html
- cgi-bin/acatalog/Kinases_-_Advanced_Strategies_and_Multiple_Targets_for_Drug_Discovery.html
- cgi-bin/acatalog/Assay_Development_and_Technologies__2nd_Edition.html
- cgi-bin/acatalog/Managing_Toxicology_for_the_Future_-_Improving_Predictive_Power_Through_Integrated_Technologies__2nd_Edition.html
- cgi-bin/acatalog/Ion_Channels_and_G_Protein-coupled_Receptors__GPCRs__Qualitative_and_Quantitative_Analysis.html
- cgi-bin/acatalog/The_Bioprocessing_Industry_-_Increasing_Capacity__Production__and_Efficiency__2nd_Edition.html
- cgi-bin/acatalog/Good_Manufacturing_Practices_3rd_Edition.html
- cgi-bin/acatalog/High_Growth_Diagnostics_-_Technology_and_Market_Analyses.html
- cgi-bin/acatalog/Life_Science_Mergers___Acquisitions.html
- Drug and Market Development Guides
- cgi-bin/acatalog/Guide_to_Business_Plan_Writing__2nd_Edition.html
- cgi-bin/acatalog/Due_Diligence_in_Life_Science_Transactions__2nd_Edition.html
- cgi-bin/acatalog/Guide_to_Good_Clinical_Practice__3rd_Edition.html
- cgi-bin/acatalog/Guide_to_Good_Facility_Design_2nd_Edition.html
- cgi-bin/acatalog/Guide_to_Good_Validation_Practice_3rd_Edition.html
- cgi-bin/acatalog/Guide_to_Good_Laboratory_Practice_3rd_Edition.html
- cgi-bin/acatalog/Preparing_the_Common_Technical_Document_CTD_for_CMC.html
- cgi-bin/acatalog/Life_Sciences_Mergers___Acquisitions__M_A_.html
- Visiongain Publishers
- cgi-bin/acatalog/Alzheimer_s_Disease_Market_analysis_and_forecasts__2007-2012__2017_and_2022.html
- cgi-bin/acatalog/Multiple_Sclerosis_Market_Analysis___Forecasts_Report_2007-2022.html
- cgi-bin/acatalog/The_World_Hypertension_Market_2007-2023.html
- cgi-bin/acatalog/The_World_Diabetes_Market_2006-2012_2017_2025_A_Key_Pharmaceutical_Market_of_the_Future.html
- cgi-bin/acatalog/The_Global_Pain_Pharmaceutical_Market_Analysis_and_Forecasts_2007-2022.html
- cgi-bin/acatalog/Blockbuster_Drugs_Create__Develop_and_Market_a_Billion_Dollar_Drug_2007-2012.html
- cgi-bin/acatalog/The_Global_Non-Opioid_Market_in_Pain_Management_2007-2022.html
- cgi-bin/acatalog/Lou_Gehrig_Disease_Report_Is_there_a_link_between_Lipitor_and_ALS_.html
- cgi-bin/acatalog/Top_Companies_and_Products_in_the_RNA_DNA_Therapy_Products_Market_Forecasts_The_challenge_of_turning_technology_into_therapy.html
- cgi-bin/acatalog/Anti-Obesity_Treatments_2007_to_2012_A_blockbuster_target_market.html
- cgi-bin/acatalog/Global_Smoking_Cessation_Market_Analysis_and_Forecasts_Preparing_for_the_first_blockbuster.html
- cgi-bin/acatalog/Parallel_Trade_US_Lawmakers_allow_imported_prescriptions_drugs.html
- cgi-bin/acatalog/Rimonabant_The_first_of_the_Cannabinoid_blockbusters.html
- cgi-bin/acatalog/Neurodegenerative_Disease_Drug_Market_Analysis_and_Forecasts_2007.html
- cgi-bin/acatalog/Gastrointestinal_Disorders_Market_Intelligence_to_2012.html
- cgi-bin/acatalog/Teva_Pharmaceutical_Industries_Market_Forecasts_and_Analysis_2007_to_2012.html
- cgi-bin/acatalog/Global_Ophthalmic_Market_Analysis_and_Forecasts_to_2012.html
- cgi-bin/acatalog/Dr_Reddy_s_Market_Outlook_Forecasts_and_Analysis_to_2012.html
- cgi-bin/acatalog/GSK_s_Cervarix_a_future_blockbuster_of_2007.html
- cgi-bin/acatalog/Cannabinoid_Market_Forecasts_and_Analysis_to_2012.html
- cgi-bin/acatalog/AMD_Market_Outlook_to_2012.html
- cgi-bin/acatalog/The_Global_Rheumatoid_Arthritis_Market_Forecasts_to_2012.html
- cgi-bin/acatalog/Tissue_Engineering_and_Stem_Cell_Technology_Report_2007.html
- cgi-bin/acatalog/Novartis_Market_Outlook_Forecasts_and_Analysis_to_2012.html
- cgi-bin/acatalog/Biological_Drug_Delivery_2007-2012.html
- cgi-bin/acatalog/The_Autoimmune_Inflammatory_Bowel_Disease_Market_Outlook_to_2012.html
- cgi-bin/acatalog/Theranostics_Report_2007-2012_.html
- cgi-bin/acatalog/Stem_Cells_-_The_hype_and_the_hope_-_Business_opportunities_and_forecasts.html
- cgi-bin/acatalog/World_market_for_cancer_vaccines_2007-2012.html
- cgi-bin/acatalog/Central_and_Eastern_European_CEE_Developing_Markets_for_Pharmaceuticals_2006-2011.html
- cgi-bin/acatalog/Therapeutic_Monoclonal_Antibodies__2006-2011_Maximising_the_Growth_Potential_of_a_Stocked_Pipeline.html
- cgi-bin/acatalog/Latin_American_Developing_Markets_for_Pharmaceuticals_2006-2011.html
- cgi-bin/acatalog/Achieving_success_in_the_Developing_Asian_Pharmaceutical_Sector_2007-2011.html
- cgi-bin/acatalog/Bioinformatics_Report_-_The_forecasts_and_future_of_the_market_2006-2011.html
- cgi-bin/acatalog/Anti-addiction_Therapies__2006-2011_-_The_Pharmaceutical_Industry_s_Next_Viagra_.html
- cgi-bin/acatalog/The_World_Allergy_Market_2006-2011_-_The_Rx-OTC_Rush.html
- cgi-bin/acatalog/The_Global_Biotech_Report_2006_-_The_rise_of_the_Biotech_blockbusters.html
- cgi-bin/acatalog/Developing_Markets_for_Pharmaceuticals__2006-2011.html
- cgi-bin/acatalog/The_World_Asthma_and_COPD_Treatment_Market__2006-2011_-_A_Changing_Market_with_Increasing_Potential.html
- cgi-bin/acatalog/The_World_Contract_Research_and_Manufacturing_Market__2006-2011_-_Trends_in_Outsourcing.html
- cgi-bin/acatalog/ePharma_-_The_Online_Pharmaceutical_Industry__2006-2011.html
- cgi-bin/acatalog/Pharmacovigilance_-_Risk_Management_in_Practice.html
- cgi-bin/acatalog/Nanomedicine_2006-2011.html
- Datamonitor
- cgi-bin/acatalog/Stakeholder_Opinions_Head_and_Neck_Cancer.html
- cgi-bin/acatalog/Commercial_and_Pipeline_Insight_-_Systemic_antifungals.html
- cgi-bin/acatalog/Pipeline_Insight_-_Orphan_Diseases_in_CNS_-_Part_I_Huntington_s_Disease.html
- cgi-bin/acatalog/Licensing_Strategies_-_Examining_Today_s_Pharmaceutical_Licensing_Trends.html
- cgi-bin/acatalog/Pipeline_Insight_-_Substance_Dependence_-_Part_I_-_Nicotine.html
- cgi-bin/acatalog/Commercial_and_Pipeline_Insight_-_Hepatitis_B.html
- cgi-bin/acatalog/Cardiovascular_market_overview_-_Raft_of_patent_expires_threaten_blockbusters.html
- cgi-bin/acatalog/Molecular_Targeted_Cancer_Therapies__Can_anything_else_revolutionize_the_market.html
- cgi-bin/acatalog/Analysis_of_the_Pharmaceutical_Market_to_2012_-_Segmented_by_Drug_Target_Family.html
- cgi-bin/acatalog/Acute_Stroke_-_TPA_spurs_infrastructure_changes_for_the_better.html
- cgi-bin/acatalog/Renal_Cancer_-_Targeted_therapies_rapidly_take_hold_of_market.html
- cgi-bin/acatalog/Antithrombotics_-_Market_expands_as_disease_management_focuses_on_prevention.html
- cgi-bin/acatalog/Infertility_-_Optimizing_a_market_bounded_by_social_opinion_and_physician_preference.html
- cgi-bin/acatalog/Commercial_and_Pipeline_Insight_Allergic_Rhinitis.html
- cgi-bin/acatalog/Upper_GI_Disorders_-_Innovation_needed_to_overcome_generic_threat.html
- cgi-bin/acatalog/HIV_Therapy_Dynamics.html
- cgi-bin/acatalog/Orthopedics__Global_Industry_Guide.html
- cgi-bin/acatalog/Biotechnology__Global_Industry_Guide.html
- cgi-bin/acatalog/Generics__Global_Industry_Guide.html
- cgi-bin/acatalog/Biosimilars_Series_Strategic_issues_-_Potential_remains_uncertain.html
- cgi-bin/acatalog/Cancer_Overview_-_Increasing_diversity_offers_both_high_risk_and_reward.html
- cgi-bin/acatalog/Parkinson_s_Disease_-_Market_to_grow_as_first_round_of_lifecycle_management_strategies_succeed.html
- cgi-bin/acatalog/Pricing_and_Reimbursement_Series_NICE__its_impact_on_the_UK_healthcare_system_and_beyond.html
- cgi-bin/acatalog/Neuropathic_Pain_-_Emerging_drugs_fail_to_capitalize_in_lucrative_market.html
- cgi-bin/acatalog/Migraine_-_Opportunities_will_exist_in_the_wake_of_generic_attack.html
- cgi-bin/acatalog/Monoclonal_Antibodies_Report_Part_II__Companies_-_Holding_mAbs_in_portfolio_promises_protection_against_the_looming_2011-12_patent_cliff.html
- cgi-bin/acatalog/Osteoporosis_Intermittent_dosing_drives_market_growth.html
- cgi-bin/acatalog/Biosimilars_Series_Regulatory_and_development_issues_hurdles_exist_but_are_surmountable.html
- cgi-bin/acatalog/Hospital_Antibacterials_A_market_beyond_MRSA.html
- cgi-bin/acatalog/Business_Blogging_for_Pharma.html
- cgi-bin/acatalog/Antidiabetics_Safety_becomes_the_critical_factor_for_success.html
- cgi-bin/acatalog/Launch_Strategies_Analyzing_Market_Trends_and_Regulatory_Impacts.html
- cgi-bin/acatalog/Heart_failure_Weak_pipeline_dominated_by_new_indications_and_add-on_diuretics.html
- cgi-bin/acatalog/R_D_Strategies_Incremental_improvements_and_paradigm_shifts_in_strategy_are_both_necessary_to_boost_productivity.htm
- cgi-bin/acatalog/Female_Sexual_Dysfunction_Prescription_Drug_Pipeline_Overview_2007.html
- cgi-bin/acatalog/Pediatric_and_Adolescent_Vaccines.html
- cgi-bin/acatalog/Patient_Empowerment_empowered_patients_can_change_healthcare_outcomes_and_impact_the_pharmaceutical_industry.html
- cgi-bin/acatalog/Antihypertensives_New_class_opportunity_offset_by_key_patent_expiries.html
- cgi-bin/acatalog/Antidyslipidemics_The_competitive_cost-conscious_antidyslipidemics_market_presents_challenges.html
- cgi-bin/acatalog/Asthma_and_COPD_Combination_products_still_have_blockbuster_potential.html
- cgi-bin/acatalog/HIV_Reshaping_Treatment_Paradigms.html
- cgi-bin/acatalog/Identifying_the_Divide_Between_the_Plant-floor_and_the_Enterprise_Market_Focus.html
- cgi-bin/acatalog/Top_20_Cancer_Therapy_Brands_Sales_of_targeted_therapies_overtake_cytotoxics_in_2006.html
- cgi-bin/acatalog/Disease_Management_and_Drug_Adherence_Strategies_to_support_patients_and_enhance_treatment_persistence.html
- cgi-bin/acatalog/Primary_Brain_Cancer.html
- cgi-bin/acatalog/Depression_Atypical_lifecycle_management_strategy_rejuvenates_depression_market.html
- cgi-bin/acatalog/Insomnia_Strong_brand_identity_critical_to_differentiation_in_an_increasingly_crowded_market.html
- cgi-bin/acatalog/Multiple_Sclerosis_Continued_growth_makes_the_MS_market_a_highly_attractive_investment.html
- cgi-bin/acatalog/Osteoporosis_Risk_management_and_reformulation_offer_best_defense_against_generic_onslaught.html
- cgi-bin/acatalog/Monoclonal_Antibodies_Report_Part_I.html
- cgi-bin/acatalog/Spending_on_Telehealth_Solutions_in_Europe_2007_to_2012__Databook_.html
- cgi-bin/acatalog/Spending_on_Telehealth_Solutions_in_North_America_through_2007_to_2012__Databook_.html
- cgi-bin/acatalog/Irritable_Bowel_Syndrome_Potentially_profitable_market_is_open_for_the_taking.html
- cgi-bin/acatalog/Supportive_Care_in_Oncology_Significant_growth_opportunities_exist_in_new_supportive_care_indications.html
- cgi-bin/acatalog/Hepatocellular_Carcinoma_Opportune_indication_for_novel_therapies.html
- cgi-bin/acatalog/Generic_Series_An_Introduction_to_the_Canadian_Generics_Market_Key_trends_and_leading_companies_shaping_the_market.html
- cgi-bin/acatalog/Female_Sexual_Dysfunction_Results_from_Datamonitor_s_2005_physician_survey.html
- cgi-bin/acatalog/Fibromyalgia_Potentially_lucrative_market_soon_to_become_reality.html
- cgi-bin/acatalog/Disease_Modification_in_Rheumatoid_Arthritis_Competition_for_the_anti-TNF_failure_patient_population_increases.html
- cgi-bin/acatalog/Insomnia_Targeting_the_sleep_maintenance_market.html
- cgi-bin/acatalog/Benchmarking_Patent_Expiries_Key_Factors_Affecting_Brand_Erosion_at_Patent_Expiry.html
- cgi-bin/acatalog/Antithrombotics_-_Reaching_the_untreated_prophylaxis_market.html
- cgi-bin/acatalog/Dyslipidemia_-_Pipeline_agents_unlikely_to_rejuvenate_the_market.html
- cgi-bin/acatalog/Influenza_Vaccines_-_Pandemic_threat_revitalizes_the_sector.html
- cgi-bin/acatalog/Hematological_Malignancies_-_Pursuit_for_the_next_blockbuster_intensifies.html
- cgi-bin/acatalog/Multiple_Sclerosis_The_oral_revolution.html
- cgi-bin/acatalog/Pricing_and_Reimbursement_Series_Medicare_Part_D_s_progress_so_far.html
- cgi-bin/acatalog/Asthma_Phenotypes_A_changing_paradigm.html
- cgi-bin/acatalog/Depression_Novel_drugs_to_grow_third-line_market.html
- cgi-bin/acatalog/Nosocomial_Infections_The_need_for_new_gram-negative_drugs.html
- cgi-bin/acatalog/ePrescribing_Infrastructure_and_Impact_on_the_Healthcare_Markets_in_the_US_and_EU.html
- cgi-bin/acatalog/Atopic_Dermatitis_A_high_level_of_unmet_need_creates_market_opportunities.html
- cgi-bin/acatalog/Small_Cell_Lung_Cancer_and_Malignant_Mesothelioma_Limited_R_D_activity_provides_opportunity_for_early-phase_pipeline_drugs.html
- cgi-bin/acatalog/Esophageal_Cancer_Treatment_paradigms_need_revolution_not_evolution.html
- cgi-bin/acatalog/The_Pharmaceutical_Industry_Key_trends_and_strategic_issues_shaping_the_industry.html
- cgi-bin/acatalog/eHealth_for_the_Pharmaceutical_Industry_What_companies_need_to_know_about_trends_in_physicians_and_consumers_use_of_the_Internet.html
- cgi-bin/acatalog/HIV_Change_of_guard.html
- cgi-bin/acatalog/Psoriasis_Anti-TNF_s_lead_another_indication.html
- cgi-bin/acatalog/Osteoarthritis_Market_sees_steady_growth.html
- cgi-bin/acatalog/Atherosclerosis_HDL_ApoA-I_Carotid_MRI_and_64-slice_CT_offer_opportunities_for_future_treatment.html
- cgi-bin/acatalog/Multiple_Sclerosis_Disease-modifying_efficacy_and_side_effects_guide_treatment_choice.html
- cgi-bin/acatalog/Erectile_Dysfunction_Identifying_product_differentiation_and_patient_segmentation_strategies.html
- cgi-bin/acatalog/Melanoma_Lucrative_commercial_opportunities_persist.html
- cgi-bin/acatalog/Respiratory_Syncytial_Virus_RSV_A_market_yet_to_reach_its_full_potential.html
- cgi-bin/acatalog/Taking_CRM_to_the_Next_Level_Web-assisted_relationship-_and_community-building_for_the_pharmaceutical_industry.html
- cgi-bin/acatalog/The_Pharmaceutical_Company_Outlook_to_2011_Financial_and_Strategic_Analysis_of_the_Sales_Outlook_for_Big_Pharma_Mid_Pharma_Japan_Pharma_and_Biotech.html
- cgi-bin/acatalog/Biosimilars_Benchmarking_the_key_players_With_increasing_regulatory_clarity_and_high_revenue_potential_interest_in_biosimilars_increases.html
- cgi-bin/acatalog/Obesity_Lack_of_Reimbursement_Limits_Market_Potential.html
- cgi-bin/acatalog/Antibacterials_Growth_in_resistance_rates_drives_niche_indications.html
- cgi-bin/acatalog/Therapeutic_Cancer_Vaccines_A_turbulent_path_from_bench_to_bedside.html
- cgi-bin/acatalog/Alzheimer_s_Disease_Prescribing_trends_indicate_that_neurologists_are_not_adhering_to_guidelines.html
- cgi-bin/acatalog/Chinese_Pharmaceutical_Market_Overview_Regulatory_reform_and_the_evolving_healthcare_market_provide_opportunities_in_china.html
- cgi-bin/acatalog/Antithrombotics_Pipeline_products_to_dampen_the_impact_of_patent_expiries_and_cost_containment_initiatives.html
- cgi-bin/acatalog/Migraine_Innovation_essential_as_weak_late-stage_pipeline_fails_to_hold_off_the_impact_of_triptan_patent_expiries.html
- cgi-bin/acatalog/Pricing_and_Reimbursement_in_Oncology_Do_payers_believe_oncology_drugs_offer_good_value.html
- cgi-bin/acatalog/Gynecological_Cancers_Niche_opportunities_in_advanced_disease.html
- cgi-bin/acatalog/Biosimilars_Regulatory_Issues_Europe_continues_to_make_strides_while_the_US_lags_behind.html
- cgi-bin/acatalog/Drug_Delivery_Global_Industry_Guide.html
- cgi-bin/acatalog/Biotechnology_Global_Industry_Guide.html
- cgi-bin/acatalog/copy_of_Next-Generation_Nutraceuticals_Food_and_pharma_convergence_in_disease_prevention_and_personalized_nutrition.html
- cgi-bin/acatalog/Generics_Global_Industry_Guide.html
- cgi-bin/acatalog/Optimizing_Sales_Force_Effectiveness_From_quantity_to_quality.html
- cgi-bin/acatalog/Inflammatory_Bowel_Disease_Competition_Increases_for_the_Biologics.html
- cgi-bin/acatalog/Respiratory_Tract_Infections_in_the_USA_The_demise_of_narrow-spectrum_antibiotics.html
- cgi-bin/acatalog/Emerging_eHealth_Technologies_Key_trends_impacting_the_physician-patient_relationship.html
- cgi-bin/acatalog/Breakthrough_Pain_Fast-acting_players_will_capture_majority_market_share.html
- cgi-bin/acatalog/Osteoarthritis_The_Wait_for_a_DMOAD_Continues.html
- cgi-bin/acatalog/Pricing_and_Reimbursement_in_Japan_Costly_healthcare_system_inefficiencies_increase_the_focus_on_healthcare_cost_containment.html
- cgi-bin/acatalog/Hormonal_Contraceptives_New_directions_in_a_competitive_market.html
- cgi-bin/acatalog/Regulator_Perceptions_in_Cancer_Evolving_opinions_about_the_oncology_drug_approval_process.html
- cgi-bin/acatalog/Non-Small_Cell_Lung_Cancer_The_need_to_differentiate_in_an_increasingly_crowded_and_fragmented_market.html
- cgi-bin/acatalog/copy_of_Innovation_in_Drug_Delivery_The_future_of_nanotechnology_and_non-invasive_protein_delivery.html
- cgi-bin/acatalog/Asthma_COPD_Targeted_therapies_on_the_horizon.html
- cgi-bin/acatalog/Epilepsy_Pipeline_drugs_struggle_to_outshine_their_marketed_predecessors.html
- cgi-bin/acatalog/Colorectal_Cancer_Shaping_the_future_dynamics_of_colorectal_cancer_management.html
- cgi-bin/acatalog/Pipeline_Commercial_Insight_Molecular_Targeted_Cancer_Therapies_More_drugs_on_the_market_more_targets_in_the_pipeline.html
- cgi-bin/acatalog/Stakeholder_Insight_Atrial_Fibrillation_Limited_efficacy_and_poor_safety_lead_to_bleak_outlook.html
|
